CSTE:NASDAQCaesarstone Ltd. Analysis
Data as of 2026-06-18 - not real-time
$1.85
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical outlook: The short‑term moving average sits above the medium‑term average, which in turn is above the long‑term average, reinforcing a bullish trend despite a recent bearish MACD signal and a slight negative histogram. RSI remains in the upper‑mid range, indicating momentum is still intact, while decreasing volume and a looming support level suggest short‑term caution.
Fundamental backdrop: The company reports declining revenue and negative profitability metrics, with high leverage and modest cash reserves. However, valuation signals are compelling: price‑to‑book is well under one, price‑to‑sales is low, and a discounted cash flow model points to a valuation many times the current market price. No dividend is paid, and the stock trades in a highly volatile environment with an elevated beta, underscoring significant risk but also potential upside for patient investors.
Fundamental backdrop: The company reports declining revenue and negative profitability metrics, with high leverage and modest cash reserves. However, valuation signals are compelling: price‑to‑book is well under one, price‑to‑sales is low, and a discounted cash flow model points to a valuation many times the current market price. No dividend is paid, and the stock trades in a highly volatile environment with an elevated beta, underscoring significant risk but also potential upside for patient investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- price approaching immediate support
- bearish MACD signal
- declining trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- potential bounce toward resistance
- valuation gap versus DCF
- ongoing earnings weakness
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- substantial upside implied by discounted cash flow
- low price‑to‑book and price‑to‑sales multiples
- possibility of operational turnaround despite current losses
Key Metrics & Analysis
Financial Health
Revenue Growth-10.90%
Profit Margin-37.71%
P/E Ratio-1.9
ROE-76.83%
ROA-6.50%
Debt/Equity88.92
P/B Ratio0.5
Op. Cash Flow$-30163000
Free Cash Flow$28.0M
Industry P/E31.4
Technical Analysis
TrendBullish
RSI58.1
Support$1.66
Resistance$2.04
MA 20$1.81
MA 50$1.64
MA 200$1.54
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14
Valuation
Fair Value$9.14
GradeUndervalued
TypeValue
Risk Assessment
Beta1.40
Volatility74.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.